Top Industry News

Eli Lilly and Company has announced plans to invest more than $6 billion in a new small-molecule active pharmaceutical ingredient (API) and peptide manufacturing facility in Huntsville, Alabama. The expansion is part of the company’s multi-year $50-billion investments in US…

Novo Nordisk has completed its acquisition of Akero Therapeutics, a South San Franciso, California-based clinical-stage bio/pharma company focused on metabolic diseases, including metabolic dysfunction-associated steatohepatitis (MASH), in a deal worth…

The US Food and Drug Administration (FDA) has named Tracy Beth Høeg, M.D., Ph.D., currently Senior Advisor for Clinical Sciences in the Office of the Commissioner and the Center for Biologics…

The latest from CDMOs, CMOs, and suppliers featuring AtomVie, Cytiva/Fida Biosystems, Tjoapack, Bora Pharmaceuticals, Quotient Sciences/Intrepid Labs, CABB Chemicals, Quvara Medical, Pace, Evonik, Aptar, Sever Pharma, AmbioPharm and Benunvia/Cannovian.   Chemicals/Chemical API Manufacturing * AtomVie Investing $138 M in New Radiopharma Mfg Facility * CABB Chemicals…

A roundup of news from Viatris/Biocon, Sanofi/ViceBio, Eli Lilly and Company/Adverum Biotechnologies and Pfizer/YaoPharma. Highlights below.   General * Biocon To Buy Out Viatris in Biocon Biologics for $815 M  M&A News * Sanofi Completes Acquisition of Vicebio in $1.6-Bn Deal*…

AstraZeneca has announced plans to invest $2 billion to expand its manufacturing footprint in Maryland. This includes an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in…

Celltrion Group, an Incheon, South Korea-based bio/pharmaceutical company, has announced plans to invest KRW 700 billion ($478 million) to expand a former Lilly active pharmaceutical ingredient (API) manufacturing facility in the US. Celltrion completed the acquisition of…

The US government has released the negotiated drug prices for a second slate of drugs—15 drugs in all–under the Medicare Drug Price Negotiation Program, which was authorized under the Inflation Reduction Act,…

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scentific, Excelsior, Microsize, AGC Biologics/Atum, Piramal Pharma Solutions, Rentschler Biopharma/Coriolis Pharma, Vetter, WuXi Biologics, Cellares, Cencor, and Sudpack.   Chemicals/Chemical API Manufacturing * Excelsior Raises $95 M For Small-Molecule Mfg Research * Microsize To Acquire Micronization Facility from Lonza * Piramal…

A roundup of news from Daiichi Sankyo/Pfizer’s Seagen, AbbVie/Bio Med X, and Tanabe Pharma. Highlights below.   Patent News * Daiichi Sanyko Wins Favorable Court Ruling in ADC Patent Dispute with Pfizer’s Seagen Partnering News * AbbVie, Bio Med X in Neuroscience…